Asano K - Search Results

1

Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.

Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T. Maehata Y, et al. Among authors: asano k. Gastrointest Endosc. 2012 Jan;75(1):39-46. doi: 10.1016/j.gie.2011.08.030. Epub 2011 Oct 21. Gastrointest Endosc. 2012. PMID: 22018552

2

Therapeutic strategy for Crohn's disease with a loss of response to infliximab: a single-center retrospective study.

Nagata Y, Esaki M, Umeno J, Fuyuno Y, Ikegami K, Maehata Y, Asano K, Moriyama T, Nakamura S, Kitazono T, Matsumoto T. Nagata Y, et al. Among authors: asano k. Digestion. 2015;91(1):50-6. doi: 10.1159/000368815. Epub 2015 Jan 20. Digestion. 2015. PMID: 25632918

3

Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis.

Asano K, Esaki M, Umeno J, Hirano A, Maehata Y, Moriyama T, Nakamura S, Matsumoto T, Kitazono T. Asano K, et al. J Gastroenterol. 2015 Nov;50(11):1094-102. doi: 10.1007/s00535-015-1062-3. Epub 2015 Mar 19. J Gastroenterol. 2015. PMID: 25787843

4

Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience.

Nuki Y, Esaki M, Asano K, Maehata Y, Umeno J, Moriyama T, Nakamura S, Matsumoto T, Kitazono T. Nuki Y, et al. Among authors: asano k. Scand J Gastroenterol. 2016;51(6):700-5. doi: 10.3109/00365521.2016.1138239. Epub 2016 Jan 28. Scand J Gastroenterol. 2016. PMID: 26818468

5

Metastatic duodenal carcinoid tumor.

Miyazaki SM, Tada S, Asano K, Kamio T, Matsumoto T. Miyazaki SM, et al. Among authors: asano k. Gastrointest Endosc. 2004 May;59(6):694. doi: 10.1016/s0016-5107(04)00165-8. Gastrointest Endosc. 2004. PMID: 15114315 No abstract available.

6

Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study.

Asano K, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Arima H, Shirota T, Matsumoto T, Iida M, Kiyohara Y. Asano K, et al. Int J Cancer. 2008 Feb 15;122(4):909-14. doi: 10.1002/ijc.23191. Int J Cancer. 2008. PMID: 17957783 Free article.

7

Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximab.

Fujioka S, Nakamichi I, Esaki M, Asano K, Matsumoto T, Kitazono T. Fujioka S, et al. Among authors: asano k. J Gastroenterol Hepatol. 2014 Jun;29(6):1207-14. doi: 10.1111/jgh.12523. J Gastroenterol Hepatol. 2014. PMID: 24447044

8

Strongyloidiasis.

Asano K, Tada S, Kamio T, Matsumoto T, Suko H, Iida M. Asano K, et al. Gastrointest Endosc. 2004 Oct;60(4):606-7. doi: 10.1016/s0016-5107(04)01861-9. Gastrointest Endosc. 2004. PMID: 15472693 No abstract available.

9

[Recent advances in genetic research of inflammatory bowel disease].

Asano K, Umeno J, Matsumoto T. Asano K, et al. Nihon Shokakibyo Gakkai Zasshi. 2011 Dec;108(12):1967-76. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 22139483 Review. Japanese. No abstract available.

10

Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis.

Asano K, Matsumoto T, Umeno J, Hirano A, Esaki M, Hosono N, Matsui T, Kiyohara Y, Nakamura Y, Kubo M, Kitazono T. Asano K, et al. Inflamm Bowel Dis. 2013 Sep;19(10):2061-8. doi: 10.1097/MIB.0b013e318298118e. Inflamm Bowel Dis. 2013. PMID: 23917248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,988 results

Search Page